A leukocytoclastic vasculitis case due to tenofovir use Tenofovir kullanımına bağlı gelişen lökositoklastik vaskülit olgusu


Solay A. H., ESER F., TÜTÜNCÜ E. E., Gencler B., ÖNDER E.

Journal of Clinical and Analytical Medicine, cilt.8, ss.231-233, 2017 (Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 8
  • Basım Tarihi: 2017
  • Doi Numarası: 10.4328/jcam.5166
  • Dergi Adı: Journal of Clinical and Analytical Medicine
  • Derginin Tarandığı İndeksler: Scopus
  • Sayfa Sayıları: ss.231-233
  • Anahtar Kelimeler: Tenofovir, Leukocytoclastic Vasculitis, Side Effect
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

The antiviral agent tenofovir disoproxil fumarate is an acyclic nucleotide analogue, which has been approved in 2008 for the treatment of hepatitis B. The most common side effects are nausea, vomiting, diarrhea, nephrotoxicity, and hepatotoxicity. Nevertheless, side effects with dermal involvement are rare. Cutaneous leukocytoclastic vasculitis can be induced by many drugs, but the tenofovirinduced case has not been reported previously. To best of our knowledge, we present the first case of tenofovir induced cutaneous leukocytoclastic vasculitis at the 4th week of treatment of chronic hepatitis B.